New Jersey · 2026-2027 Regular Session · Bill

A 2120: Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.

In committee Last action January 13, 2026: Introduced, Referred to Assembly Aging and Human Services Committee

Plain-language summary

A 2120 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate. Primary sponsor: Linda Carter (Democratic), Mike Venezia (Democratic), Verlina Reynolds-Jackson (Democratic). It lists 1 additional sponsor. Most recent recorded action (January 13, 2026): Introduced, Referred to Assembly Aging and Human Services Committee.

Sponsors

Primary sponsors: Linda Carter (Democratic); Mike Venezia (Democratic); Verlina Reynolds-Jackson (Democratic). 1 co-sponsor.